Drug manufacturing

Aurobindo Pharma’s shares closed with a loss of 3.7% as investors feared it may face delays in resolving the issue. Graphic: Naveen Kumar Saini/Mint

US FDA: a risk that keeps on giving

3 min read . 06 Mar 2018
The promise of a forward-looking bio-pharmaceutical industry in India will only be fulfilled if we work to build an ecosystem that promotes medical innovation. Photo: Mint

Balancing patents and drug prices

4 min read . 27 Nov 2017